Updated Anaphylaxis Guidelines

Use of epinephrine is stressed, and recommendations are given for managing biphasic reactions.

Sponsoring Organizations: The Joint Task Force on Practice Parameters (from the American Academy of Allergy, Asthma & Immunology [AAAAI] and the American College of Allergy, Asthma, and Immunology [ACAAI])

Background

As many as 5% of people experience anaphylaxis in their lifetime, with medications and stinging insects being the leading causes of anaphylaxis in adults, and foods and stings being the leading causes in children. Although overall risk for death from anaphylaxis is quite low (0.3% of emergency visits or hospitalizations for anaphylaxis end with fatalities), comorbid conditions, such as uncontrolled asthma, cardiovascular disease, or advanced age, are associated with excess risk.

Key Points

The only effective treatment for anaphylax…

Reviewing Author

David J. Amrol, MD

Disclosures

Speaker’s BureauAstraZeneca; Incyte

David J. Amrol, MD

Disclosures

Speaker’s BureauAstraZeneca; Incyte

Updated Anaphylaxis Guidelines

Topics

Background

Key Points

Reviewing Author